91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
.jpg?w=545&itok=7luDTQY4 "IPT discussed in technical publications.")
Concierge services are critical to helping patients navigate technology and other logistics in a decentralised clinical trial. Laney Preheim outlines
This article is taken fromInnovations in Pharmaceutical Technology, October 2022, pages 34-36 . Samedan Ltd
-
What Biotech and Pharma need to consider about decentralised trials
Discuss key considerations when implementing decentralised clinical trials, in addition to the success factors that lead to more patient-centric trials and increased patient recruitment, engagement and retention.
-
Dr. Isaac R. Rodriguez-Chavez outlines .
-
Dr. Isaac R. Rodriguez-Chavez offers his insights on .
International Clinical Trials, May 2022, pages 54-57. Samedan Ltd
-
Matt Harrington, VP of Connected Health Technology Solutions, explores how .
-
In , Steve Cutler comments on 91黑料’s success in decentralised trials and therapeutic technologies such as mRNA and checkpoint inhibitors.
-
Advances in wearables, telemedicine and remote monitoring technology along with the convenience of in-home visits were bound to make decentralised and hybrid clinical trials standard with enough time. However, the COVID-19 pandemic accelerated their adoption and now, even with the hope that the pandemic will soon be behind us, hybrid and decentralised models are poised to become viable solutions in clinical trial design because of their inherent agility, inclusivity and most importantly, patient centricity.
-
Emily Mitchell, Executive Director, Decentralised Clinical Trials Operations and Christina Dinger, Director, Decentralised Clinical Trials Operations, run through .
This article was taken from Pharmafocus December 2021, pages 16-17. Samedan Ltd.
-
reporting on 91黑料's recent announcement that its Accellacare Site Network has entered new partnerships with six research sites across four countries, expanding its global footprint and capabilities.
-
This article highlights .
.jpg?w=340&itok=vvIkDfgO "IPT discussed in technical publications."){kind=icon}
